Early detection of choroidal neovascularization in age related macular degeneration

Early detection of choroidal neovascularization in age related macular degeneration

Show other versions (1)

Purpose: to identify factors associated with early detection of choroidal neovascularization CNV in clinical practice.Methods: Seventy six AMD patients who had history of CNV in one eye and presented with CNV in the second eye and evaluated for association with visual acuity (VA) at time of presenta...

Full description

Bibliographic Details
Main Author:	Tural Galbinur
Format:	Article
Language:	Russian
Published:	Ophthalmology Publishing Group 2014-07-01
Series:	Oftalʹmologiâ
Subjects:	возрастная макулярная дегенерация хориоидальная неоваскуляризация ранняя диагностика
Online Access:	https://www.ophthalmojournal.com/opht/article/view/133

Similar Items

Myopia and age-related macular degeneration: structural and anatomical changes of the eye
by: I. B. Alekseev, et al.
Published: (2019-08-01)

Cataract surgery in patients with age-related macular degeneration: questions and controversies
by: E. I. Dmitrieva, et al.
Published: (2022-03-01)

Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration
by: I. B. Alekseev, et al.
Published: (2018-10-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

An Experimental and Clinical Justification for Prolongation of Action of Anti-VEGF Drug in the “Wet” Form Age-related Macular Degeneration by the Introduction in the Back Subtenon Space on the Basis of Viscous Media
by: R. V. Gaybaryan, et al.
Published: (2017-03-01)

Mixed (combined) phenotype of the late stage of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-06-01)

An integrated analysis of clinical and morphometric indications of atrophic forms of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2022-01-01)

Treatment of macular diseases: an overview of key randomized clinical trials
by: E. V. Bobykin, et al.
Published: (2022-01-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

The Significance of Screening Questionnaire in the Evaluation of Age-Related Macular Risk Degeneration Development
by: L. A. Kochmasheva, et al.
Published: (2019-12-01)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

The results of diagnostic and treatment of patients with diabetic retinopathy and age-related macular degeneration at a diabetes type 2.
by: I. V. Vorobyova, et al.
Published: (2014-10-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

The role of free-radical processes in the pathogenesis of age-related macular degeneration. Review
by: A. V. Kolesnikov, et al.
Published: (2014-07-01)

The Use of Nutraceuticals in Patients with “Dry” Form of Age-Related Macular Degeneration on the Background of Accelerated Aging
by: S. A. Korotkih, et al.
Published: (2019-06-01)

To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review
by: V. G. Likhvantseva, et al.
Published: (2021-10-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Our Experience of Nutraceutical Effects in Age-Related Macular Degeneration
by: S. V. Yanchenko, et al.
Published: (2020-12-01)

Experiences of treatment of age related macular degeneration with concomitant myopia
by: I. B. Alekseev, et al.
Published: (2019-03-01)

Epidemiology of Age-Related Macular Degeneration in the Republic of Bashkortostan (Clinical and Statistical Analisys of the “Ural Eye and Medical Study”)
by: T. R. Gilmanshin
Published: (2019-04-01)

Efficacy of the drug Vitalux Plus of patients with dry form of age-related macular degeneration
by: I. R. Gazizova, et al.
Published: (2014-07-01)

Study of the Level of Pro- and Antiangiogenic Growth Factors in Vitreous Fluid in Neovascular Age-Related Macular Degeneration on the Background of Treatment
by: M. M. Arkhipova, et al.
Published: (2022-07-01)

Electrophysiological signs of retinal cone remodeling in geographic atrophy of the pigment epithelium in patients with non-exudative age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-09-01)

The complex model of risk and progression of AMD estimation
by: V. S. Akopyan, et al.
Published: (2014-07-01)

Efficiency of Retinoprotective Dry AMD Therapy with Neuroprotective Therapy: a Randomized Clinical Trials Meta-analysis
by: V. P. Erichev, et al.
Published: (2018-03-01)

MONITORING OF FUNCTIONAL PARAMETERS IN THE PATIENTS WITH EARLY STAGE OF AGE-RELATED MACULAR DEGENERATION
by: I. A. Gndoyan, et al.
Published: (2017-10-01)

Nutraceuticals for Age-Related Macular Degeneration: Formulation Optimization Focused on Safety
by: E. K. Pedanova
Published: (2022-04-01)

An integrated assessment of ophthalmogeriatric changes in patients with the wet form of agerelated macular degeneration
by: A. Y. Brezhnev, et al.
Published: (2022-06-01)

Retinal clinical and morphofunctional changes in high myopia in combination with age-related macular degeneration of different stages
by: L. K. Moshetova, et al.
Published: (2022-09-01)

Hypermetropia as a Risk Factor for Age-Related Macular Degeneration. Review
by: V. G. Likhvantseva, et al.
Published: (2022-07-01)

ADVANCED MEDICAL INFORMATION TECHNOLOGY 1.0 PROGRAM APPLICATION IN THE ANALYSIS OF PATIENTS WITH THE AGE-RELATED MACULAR DEGENERATION
by: Ye. V. Melehin, et al.
Published: (2014-02-01)

Combined modality therapy for exsudative form of age-related macular degeneration
by: М. V. Budzinskaya, et al.
Published: (2013-03-01)

Combined modality therapy for exsudative form of age-related macular degeneration
by: М. V. Budzinskaya, et al.
Published: (2013-01-01)

Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration
by: D. A. Dorofeev
Published: (2018-10-01)